Abstract
Pelvic inflammatory disease (PID) is a general term connoting inflammation caused by an infection in the upper genital tract. It is a disease that has reached epidemic proportions in the 1990s and may include infection of any or all the following: endometrium, myometrium, oviducts, ovaries, uterine serosa, parametrium, or pelvic peritoneum. Pelvic inflammatory disease is inarguably an extremely serious reproductive health problem. Each year, more than 1 million U.S. women experience an episode of PID,1,2 with at least one-fourth of them suffering one or more serious, long-term sequelae.3–5
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Rolfs RT, Galaid EL, Zaidi AA. Epidemiology of pelvic inflammatory disease: trends in hospitalizations and office visits, 1979–1988. In: Proceedings of the Centers for Disease Control and National Institutes of Health joint meeting, Pelvic Inflammatory Disease: Prevention, Management, and Research in the 1990s. Bethesda, Md; September 4–5, 1990.
Washington AE, Cates W, Zaidi AA. Hospitalizations for pelvic inflammatory disease: epidemiology and trends in the United States, 1975 to 1982. JAMA. 1984; 251: 2529–2533.
Westrom L. Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol. 1980; 138: 880–892.
Cates W, Rolfs RT, Aral SO. Sexually transmitted diseases, pelvic inflammatory disease and infertility: an epidemiologic update. Epidemiol Rev. 1990; 12: 199–220.
Sweet RL. Pelvic inflammatory disease. In: Sweet RL, Gibbs RS, eds. Infectious Diseases of the Female Genital Tract. Baltimore, Md: Williams & Wilkings; 1990: 241–266.
Washington AE, Katz P. Cost of the payment source for pelvic inflammatory disease: trends and Projections, 1983 through 2000. JAMA. 1991; 266: 2565–2569.
Westrom L, Svensson L, Wolner-Hanssen P, Mardh P-A. Chlamydial and gonococcal infection in a defined population of women. Scand J Infect Dis. 1982; 32 (suppl): 157–162.
Mardh P-A. An overview of infectious agents in salpingitis: their biology, and recent advances in methods of detection. Am J Obstet Gynecol. 1980; 138: 933–951.
Sweet RL, Draper DL, Hadley WK. Etiology of acute salpingitis: influence of episode number and duration of symptoms. Obstet Gynecol. 1981; 58: 62–68.
Eschenbach DA, Harnisch JP, Holmes KK. Pathogenesis of acute pelvic inflammatory disease: role of contraception and other risk factors. Am J Obstet Gynecol. 1977; 128: 838–850.
Hadley WK, Brooks GF. Microbiology and pathogenesis of acute salpingitis as determined by laparoscopy: what is the appropriate site to sample? Am J Obstet Gynecol. 1980;138:985–989.
Eschenbach DA, Buchanan TM, Pollock HM, et al. Polymicrobial etiology of acute pelvic inflammatory disease. N Engl J Med. 1975; 293: 166–172.
Thompson SE, Hager WD, Wong KH, et al. The microbiology and therapy of acute pelvic inflammatory disease in hospitalized patients. Am J Obstet Gynecol. 1980; 136: 179–186.
Droegemueller W. Upper genital tract infections. In: Droegemueller W, Herbst AL, Mishell DR Jr., Stenchever MA, eds. Comprehensive Gynecology. St. Louis, Mo: CV Mosby; 1987: 614–642.
Rice PA, Schacter J. Pathogenesis of pelvic inflammatory disease. JAMA. 1991;266:2587–2593.
James AN, Knox JM, Williams RP. Attachment of gonococci to sperm: influence of physical and chemical factors. Br J Vener Dis. 1975; 52: 128–135.
Wolner-Hanssen P, Mardh P-A. In vitro tests of the adherence of Chlamydia trachomatis to human spermatozoa. Fertil Steril. 1984;42:102–107.
Keith LG, Berger GS, Edelman DA, et al. On the causation of pelvic inflammatory disease. Am J Obstet Gynecol. 1984; 149: 215–224.
Patton DL, Haibert SA, Kuo CC, Wang SP, Holmes KK. Host response to primary Chlamydia trachomatis infection of the fallopian tube in pigtailed monkeys. Fertil Steril. 1983; 40: 829–840.
Patton DL, Kuo CC, Wang SP, Haibert SA. Distal obstruction induced by repeated Chlamydia trachomatis salpingeal infections in pig- tailed macaques. J Infect Dis. 1987; 155: 1292–1299.
Patton DL, Landers DV, Schacter J. Experimental Chlamydia trachomatis salpingitis in mice: initial studies on the characterization of the leukocyte response to chlamydial infection. J Infect Dis. 1989; 159: 1105–1110.
McGeer ZA, Johnson AP, Taylor-Robinson D. Pathogenic mechanisms of Neisseria gonorrhoeae: observations on damage of human fallopian tubes in organ culture by gonococci of colony type 1 or type 4. J Infect Dis. 1981; 143: 413–422.
Gregg CR, Melly MA, Hellerqvist CG, Con- iglio JG, McGee ZA. Toxic activity of purified lipopolysaccharide of Neisseria gonorrhoeae for human fallopian tube mucosa. J Infect Dis. 1981; 143: 432–439.
Melly MA, McGee ZA, Rosenthal RS. Ability of monomeric peptidoglycan fragments from Neisseria gonorrhoeae to damage human fallopian-tube mucosa. J Infect Dis. 1984; 149: 378–386.
Densen P, MacKeen LA, Clark RA. Dissemination of gonococcal infection is associated with delayed stimulation of complement- dependent neurophil Chemotaxis in vitro. Infect Immun. 1982; 80: 78–87.
Bell TA, Holmes KK. Age-specific risks of syphilis, gonorrhea, and hospitalized pelvic inflammatory disease in sexually experienced U.S. women. Sex Transm Dis. 1984;11:291–295.
Wolner-Hanssen P, Eschenbach DA, Paavo- nen J, et al. Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use. JAMA. 1990; 263: 54–59.
Marchbanks PA, Lee NC, Peterson HB. Cigarette smoking as a risk factor for pelvic inflammatory disease. Am J Obstet Gynecol. 1990; 162: 639–644.
Aral SO, Mosher WD, Cates W Jr. Self- reported pelvic inflammatory disease in the United States, 1988. JAMA. 1991;266:2570–2573.
Ledegaard O, Helm P. Pelvic inflammatory disease: the influence of contraceptive, sexual and social life events. Contraception. 1990; 41: 475–483.
Lee NC, Rubin GL, Grimes DA. Measures of sexual behavior and the risk of pelvic inflammatory disease. Obstetrics and Gynecology. 1991; 77: 424–430.
Centers for Disease Control. Condoms for prevention of sexually transmitted diseases. MMWR. 1988; 37: 133–137.
Cromer BA, Heald FP. Pelvic inflammatory disease associated with Neisseria gonorrhoeae and Chlamydia trachomatis: clinical correlates. Sex Transm Dis. 1987; 14: 125–129.
Harrison HR, Costin M, Meder JB, et al. Cervical Chlamydia trachomatis infection in university women: relationship to history, contraception, ectopy, and cervicitis. Am J Obstet Gynecol. 1985; 153: 244–251.
Washington AE, Gove S, Schachter J, Sweet RL. Oral contraceptive, Chlamydia trachomatis infection, and pelvic inflammatory disease: a word of caution about protection. JAMA. 1985; 253: 2246–2250.
Senanayake P, Kramer DG. Contraception and the etiology of pelvic inflammatory disease: new perspectives. Am J Obstet Gynecol. 1980; 138: 852–860.
World Health Organization. Mechanism of Action, Safety and Efficacy of Intrauterine Devices. Geneva, Switzerland: World Health Organization; 1987; Technical report series 753.
Lee NC, Rubin GL, Ory HW, Burkman RT. Type of intrauterine device and the risk of pelvic inflammatory disease. Obstet Gynecol. 1983; 62: 1–6.
Wolner-Hanssen P, Eschenbach DA, Paavo- nen J, et al. Association between vaginal douching and acute pelvic inflammatory disease. JAMA. 1990; 263: 1936–1941.
Marchbanks PA., Lee NC, Peterson HB. Cigarette smoking as a risk factor for pelvic inflammatory disease. Am J Obstet Gynecol. 1990; 162: 639–644.
Sweet RL, Blankfort-Doyle M, Robbie MO, Schachter J. The occurrence of chlamydial and gonococcal salpingitis during the menstrual cycle. JAMA. 1986; 255: 2062–2064.
Jacobson L, Westrom L. Objectivized diagnosis of acute pelvic inflammatory disease: diagnostic and prognostic value of routine laparoscopy. Am J Obstet Gynecol. 1969; 105: 1088–1098.
Hager WD, Eschenbach DA, Spence MR, Sweet RL. Criteria for diagnosis and grading of salpingitis. Obstet Gynecol. 1983; 61: 113–114.
Hadgu A, Westrom L, Brooks CA, Reynolds GH, Thompson SE. Predicting acute pelvic inflammatory disease: a multivariate analysis. Am J Obstet Gynecol. 1986; 155: 954–960.
Paavonen J, Aine R, Teisala K, Heinonen PK, Punnonen R. Comparison of endometrial biopsy and peritoneal fluid cytologic testing with laparoscopy in the diagnosis of acute pelvic inflammatory disease. Am J Obstet Gynecol. 1985; 151: 645–650.
Bongard F, Landers DV, Lewis F. Differential diagnosis of appendicitis and pelvic inflammatory disease: a prospective analysis. Am J Surg. 1985; 150: 90–96.
Lehtinen M, Laine S. Neinonen PK, et al. Serum C-reactive protein determination in acute pelvic inflammatory disease. Am J Obstet Gynecol. 1986; 154: 158–159.
Dick JM, Kauer FM, Fleuren GJ, de Bruijin HW. Serum CA-125 levels in patients with provisional diagnosis of pelvic inflammatory disease: clinical and theoretical implications. Acta Obstet Et Gynecol Siandi. 1989; 68: 637–641.
Kahn JG, Walker CK, Washington AE, Landers DV, Sweet RL. Diagnosing pelvic inflammatory disease: a comprehensive analysis and considerations for developing a new model. JAMA. 1991; 266: 2594–2604.
Centers for Disease Control. Pelvic inflammatory disease: policy guidelines for prevention and management. MMWR. 1991; 40 (RR-5): 1–25.
Brook I. Bacterial synergy in pelvic inflammatory disease. Arch Gynecol Obstet. 1987; 241: 133–143.
Westrom L. Pelvic inflammatory disease: bacteriology and sequelae. Contraception. 1987; 36: 111–128.
Paavonen J, Teisala K, Heinonen PK, et al. Microbiological and histopathological findings in acute pelvic inflammatory disease. Br J Obstet Gynecol. 1987; 94: 454–460.
Centers for Disease Control. 1989 Sexually transmitted diseases treatment guidelines. MMWR. 1989:38(No. S-8): 31–33.
Centers for Disease Control. 1985 Sexually transmitted diseases treatment guidelines. MMWR. 1985; 34 (Suppl 4S): 19–21.
Obwegeser J, Kunz, J, Wust J, Schar G, Steiner R, Buchi W. Clinical efficacy of amoxycillin/ clavulanate in laparoscopically confirmed salpingitis. J Antimicrob Chemother. 1989; 24 (suppl B): 165–176.
McGregor JA, Christiansen FB. Treatment of obstetric and gynecologic infections, with an emphasis on beta-lactamase-producing organisms. J Reprod Med. 1988; 33 (suppl 6): 595–597.
Crombleholme WR, Landers D, Ohm-Smith M, et al. Sulbactam/ampicillin versus metro- nidazole/gentamicin in the treatment of severe pelvic infections. Drugs. 1986; 3 (suppl 2): 11–13.
Wolner-Hanssen P, Paavonen J, Kiviat N, Young M, Eschenbach DA, Holmes KK. Outpatient treatment of pelvic inflammatory disease with cefoxtin and doxycycline. Obstet Gynecol. 1988; 71: 595–600.
Apuzzio JJ, Stankiewicz R, Jain S, Kaminski Z, Louria D. Comparison of parenteral ciprofloxacin with clindamycin-gentamicin in the treatment of pelvic infection. Am J Med. 1989; 87 (suppl 5A): 148S - 151S.
Crombleholme WR, Schachter J, Ohm-Smith M, Luft J, Whidden R, Sweet RL. Efficacy of single-agent therapy for the treatment of acute pelvic inflammatory disease with ciprofloxacin. Am J Med. 1989; 87 (suppl 5A): 142S - 147S.
Peterson HB, Walker CK, Kahn JG, Washington AE, Eschenback DA, Paro S. Pelvic inflammatory disease: treatment issues and options. JAMA. 1991; 266: 2605–2611.
Dodson MG, Faro S, Gentry LO. Treatment of acute pelvic inflammatory disease with aztreonam, a new monocyclic B-lactam antibiotic and clindamycin. Obstet Gynecol. 1986; 67: 657–662.
Pastorek JG II, Cole Cm, Aldridge KE, Cra- panzano JC. Aztreonam plus clindamycin as therapy for pelvic infections in women. Am J Med. 1985; 78 (suppl 2A): 47–50.
Jones RN. Review of the in vitro spectrum of activity of imipenem. Am J Med. 1985; 78 (supple 6A): 22–32.
Duff P. Obstetrics and Gynecology Clinics of North America: Antibiotic Use in Obstetrics and Gynecology. Philadelphia, Pa:WB Saunders; 1992:Vol 19, No. 3.
American College of Obstetricians and Gynecologists. Precis III: An Update in Obstetrics and Gynecology. Washington, DC: The American College of Obstetricians and Gynecologists; 1986: 17.
Landers DV, Sweet RL. Current trends in the diagnosis and treatment of tuboovarian abscess. Am J Obstet Gynecol. 1985; 151: 1098–1110.
Sweet RL. Pelvic inflammatory disease: prevention and treatment. Modern Medicine. 1987; 55: 64–70.
Esenbach DA. Acute pelvic inflammatory disease. In: Schiarra JJ, Droegmeuller W, eds. Gynecology and Obstetrics, Rev ed. Philadelphia, Pa:JP Lippincott; 1990:(1)44:1–21
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag New York, Inc.
About this chapter
Cite this chapter
Sprang, M.L. (1993). Pelvic Inflammatory Disease. In: Knaus, J.V., Isaacs, J.H. (eds) Office Gynecology. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-4340-3_7
Download citation
DOI: https://doi.org/10.1007/978-1-4612-4340-3_7
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-8740-7
Online ISBN: 978-1-4612-4340-3
eBook Packages: Springer Book Archive